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Introduction
============

Third degree heart block is the complete block or dissociation between the atria and the ventricles and a condition when none of the atrial impulses reach the ventricle. The causes of the third degree heart block in children could be congenital \[[@REF1]\] or familial \[[@REF2]\] and in adults is related to ischemia (of atrioventricular node) or could be non-ischemic including increased vagal tone, fibrosis (Lenegre\'s disease in patients with age \<60) \[[@REF3]\], sclerosis (Lev\'s disease in patients with age \>70) of the conduction system \[[@REF4]\], electrolyte abnormalities, infiltrative diseases or iatrogenic including nodal blocking medication, cardiac surgery, catheter ablations, and transcatheter aortic valve implantation.

The clinical presentation depends on the level of the block and the escape rhythm that develops as a result \[[@REF5]\]. The escape rhythm depends on the automaticity or intrinsic rate of the tissue distil to the block \[[@REF6]\]. The escape rhythms can be divided into narrow complex or wide complex escape rhythm based on the QRS duration (whether the QRS duration is less than or more than 120 milliseconds). Junctional or atrioventricular (AV) nodal escape rhythm develops, which is a narrow complex, when the block is within the atrioventricular node or at the level of His bundle. The escape rhythm is a wide QRS complex when the block is below the His bundle (infraHisian) \[[@REF7]-[@REF8]\].

They may be asymptomatic in very few number of cases. The presenting complains mostly include weakness, dizziness, palpitation, dyspnea, or syncope \[[@REF5]\]. Diagnosis of the third degree heart block can be made by a 12-lead electrocardiogram and usually requires permanent pacemaker as treatment.

In this study, we try to understand the clinical characteristics pertaining to new onset CHB and carefully analyze the outcomes in ischemic and non-ischemic CHB patients as there is no comparison between these groups.

Materials and methods
=====================

Study design
------------

This is a retrospective observational cohort of patients admitted to the Fairview hospital from January 2014 to June 2016 with third degree heart block. The diagnosis was confirmed by an electrocardiogram by a cardiologist. The study was approved by the institutional review board of the Cleveland Clinic. Individual consent was waived because of the retrospective nature of the study.

The patients were initially identified using the International Classification of Disease (ICD) codes applied at discharge including both ICD-9 and ICD-10 codes as there was a transition during the requested time frame. In our study, 216 patients who had a third degree heart block in their billing codes were initially identified. Patients with the age \>18 years and a new diagnosis of the third degree heart block were included in the study. Patients with a pre-existing/known history of CHB and congenital heart disease were excluded from the study. This led to the exclusion of 154 patients. Data was collected by reviewing the electronic medical records. The ischemic and non-ischemic CHB were differentiated by cardiac markers elevation, ischemic electrocardiogram changes and/or cardiac catheterization. The differentiation was made by the cardiologists.

Data collection
---------------

We collected data for the following: demographics including age, gender, ethnicity and body mass index; pre-existing comorbidities including diabetes mellitus, hypertension, previous coronary artery disease, history of cardiac surgery, acute kidney injury on admission, chronic kidney disease, thyroid disease, history of cancer; use of nodal blocking agents, electrolyte abnormalities on admission and echocardiographic findings including ejection fraction, right ventricular systolic pressure (RVSP), left ventricular end diastolic and systolic volumes. The primary outcome was all-cause mortality while the secondary outcome was permanent pacemaker placement. Outcomes were assessed by follow-up in the office or last pacemaker check. During follow-up, other parameters like percentage of right ventricular pacing, underlying rhythm, battery status of the pacemaker, sensing parameters, and follow-up echocardiogram findings including ejection fraction and RVSP were also collected.

Statistical analysis
--------------------

Data analysis was performed using IBM SPSS Statistics Version 23 (IBM Corp, NY, USA). The categorical variables were compared using Fisher's exact method as there were cells with less than count of five. The continuous variables were compared using analysis of variance (ANOVA). An analysis of covariance (ANCOVA) model was created to assess the difference in initial ejection fraction and the follow-up ejection fraction to see if there was any statistically significanct difference between both groups.

Results
=======

Among the 62 patients (N=62) that met the inclusion criteria, 48 had non-ischemic complete heart block and 14 had ischemic compete heart block. Out of all the patients, 69% (43/62) were males, 37% (23/62) had diabetes mellitus, 6.4% (4/62) had hypothyroidism, 79% (49/62) had hypertension, 25.8% (16/62) had chronic kidney disease, 45.2% (28/62) had a history of coronary artery disease, 25.8% (16/62) had history of cancer, 51.6% (32/62) were on nodal blocking agents, 11.3% (7/62) were current smokers, 56.6% (35/62) were former smokers, and 32.6% (20/62) had never smoked (Table [1](#TAB1){ref-type="table"}).

###### Baseline Categorical Variables

  -------------------------------------------- -------------------------- ----------------- --------------------- -----------
  Baseline Categorical Variables                                                                                  
  Variables                                    Total             (N=62)   Ischemic (N=14)   Non-ischemic (N=48)   P - Value
  Male                                         43 (69.4%)                 12 (85.7%)        31 (64.6%)            0.12
  Female                                       19 (30.6%)                 2 (14.3%)         17 (35.4%)            
  Diabetes Present                             23 (37.1%)                 5 (35.7%)         18 (37.5%)            0.58
  Hypertension Present                         49 (79.1%)                 11 (78.6%)        38 (79.2%)            0.61
  History of thyroid Disease                   4 (6.4%)                   0 (0%)            4 (8.3%)              0.34
  History of Coronary Artery Disease Present   28 (45.2%)                 10 (71.4%)        18 (37.5%)            0.02
  History of Chronic Kidney Disease Present    16 (25.8%)                 4 (28.6%)         12 (25.0%)            0.52
  History of Cancer Present                    16 (25.8%)                 3 (21.4%)         13 (27.1%)            0.48
  Current Smoker                               7 (11.2%)                  1 (7.1%)          6 (12.5%)             0.76
  Former Smoker                                35 (56.5%)                 9 (64.3%)         26 (54.2%)            
  Never smoked                                 20 (32.3%)                 4 (28.6%)         16 (33.3%)            
  Nodal Blocking agent prescribed              32 (51.6%)                 9 (64.3%)         23 (47.9%)            0.22
  Nodal Blocking agents Not prescribed         30 (48.4%)                 5 (35.7%)         25 (52.1%)            
  -------------------------------------------- -------------------------- ----------------- --------------------- -----------

The mean age in the group with ischemic complete heart block was 67.64 years (95% CI, 60.56-74.73) and 75.60 years (95% CI, 72.00-79.21) in non-ischemic CHB (p=0.04). The mean ejection fraction in ischemic CHB group was 49.6% (95% CI, 42.05%-57.23%) compared to 57.25% (95% CI, 53.74%-60.76%) in non-ischemic CHB patients (p=0.05). A history of coronary artery disease was present in 71.4% (10/14) patients with ischemic CHB compared to 37.5% (18/48) patients with non-ischemic CHB (p=0.02). The right ventricular systolic pressure (RVSP) was 33.13 (95% CI, 21.71 - 44.54) in ischemic CHB versus 41.87 (95% CI, 36.50-47.25) in non-ischemic CHB (p=0.17), which was not statistically significant (Table [2](#TAB2){ref-type="table"}).

###### Continuous Variables

  -------------------------------------------- ------------- ------- ---------------- ------------ ---------------------------------- ------------ ------- ------
  Continuous Variables                                                                                                                                     
                                               N             Mean    Std. Deviation   Std. Error   95% Confidence Interval for Mean   P -- Value           
  Lower Bound                                  Upper Bound                                                                                                 
  Age                                          Ischemic      14      67.64            12.28        3.28                               60.56        74.73   0.04
  Non-Ischemic                                 48            75.60   12.42            1.79         72.00                              79.21                
  Total                                        62            73.81   12.73            1.62         70.57                              77.04                
  Body Mass Index                              Ischemic      12      29.50            6.72         1.94                               25.23        33.77   0.36
  Non-Ischemic                                 46            27.67   5.98             0.88         25.89                              29.45                
  Total                                        58            28.05   6.13             0.80         26.44                              29.66                
  Potassium                                    Ischemic      13      4.09             0.45         0.13                               3.81         4.36    0.10
  Non-Ischemic                                 48            4.37    0.59             0.08         4.20                               4.54                 
  Total                                        61            4.31    0.57             0.07         4.16                               4.46                 
  Magnesium                                    Ischemic      13      2.07             0.27         0.07                               1.91         2.23    0.76
  Non-Ischemic                                 46            2.05    0.26             0.04         1.97                               2.13                 
  Total                                        59            2.05    0.26             0.03         1.99                               2.12                 
  Ejection Fraction (EF)                       Ischemic      11      49.64            11.30        3.41                               42.05        57.23   0.05
  Non-Ischemic                                 44            57.25   11.55            1.74         53.74                              60.76                
  Total                                        55            55.73   11.80            1.59         52.54                              58.92                
  Right Ventricular Systolic Pressure (RVSP)   Ischemic      8       33.13            13.65        4.83                               21.71        44.54   0.17
  Non-Ischemic                                 39            41.87   16.58            2.66         36.50                              47.25                
  Total                                        47            40.38   16.32            2.38         35.59                              45.18                
  EF at follow up                              Ischemic      3       46.67            18.93        10.93                              -0.36        93.69   0.80
  Non-Ischemic                                 17            44.41   13.84            3.36         37.30                              51.53                
  Total                                        20            44.75   14.13            3.16         38.14                              51.36                
  RVSP at follow up                            Ischemic      3       39.67            23.25        13.42                              -18.08       97.41   0.66
  Non-Ischemic                                 13            35.15   14.23            3.95         26.56                              43.75                
  Total                                        16            36.00   15.41            3.85         27.79                              44.21                
  -------------------------------------------- ------------- ------- ---------------- ------------ ---------------------------------- ------------ ------- ------

For outcomes, 45/48 (93.75%) patients with non-ischemic CHB had the permanent pacemaker implanted versus 6/14 (42.83%) patients with ischemic CHB (p\<0.01). The primary outcome of death was reported in 6/48 (12.5%) patients with non-ischemic CHB compared to 3/14 (21.4%) patients in ischemic CHB group (p=0.327) (Table [3](#TAB3){ref-type="table"} and Figure [1](#FIG1){ref-type="fig"}). The overview of the study is provided in Figure [2](#FIG2){ref-type="fig"}.

###### Outcomes

  ---------------------- -------------- ----------------- --------------------- ---------
  Variable               Total (N=62)   Ischemic (N=14)   Non-ischemic (N=48)   P Value
  Primary Outcome                                                               
  Alive                  53 (85.5%)     11 (78.6%)        42 (87.5%)            0.327
  Dead                   9 (15.5%)      3 (21.4%)         6 (12.5%)             
  Secondary Outcome                                                             
  Pacemaker Placed       51 (82.3%)     6 (42.9%)         45 (93.8%)            \<0.01
  Pacemaker Not Placed   11 (17.7%)     8 (57.1%)         3 (6.3%)              
  ---------------------- -------------- ----------------- --------------------- ---------
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Further, an ANCOVA model was created to assess the difference between both groups in terms of the initial and follow-up ejection fraction (EF). Follow-up EF was reported for 20 patients out of whom three had ischemic CHB and 17 had non-ischemic CHB. There was no statistical difference (p=0.909) in the means of the EF difference at the time of diagnosis and follow-up visit.

Discussion
==========

Adult-acquired (non-ischemic) complete heart block has a poor outcome without a permanent pacemaker \[[@REF9]\]. Patients who are symptomatic do especially worse, and patients who get pacemakers do very well \[[@REF9]\]. A permanent pacemaker is indicated when no reversible cause for complete heart block is identified \[[@REF10]\]. Non-ischemic third degree heart block is hypothesized to be more frequent in patients with thyroid disease and diabetes \[[@REF11]\]. In our study, there was no difference between the ischemic and non-ischemic complete heart block with regards to diabetes or thyroid disease as suggested previously \[[@REF11]\].

The incidence of ischemic complete heart block after acute myocardial infarction has reduced \[[@REF12]-[@REF13]\]. The prognosis of acute myocardial infarction complicated by complete heart block (CHB) is poor and in-hospital death rates are significantly higher compared to patients with myocardial infarctions not associated with CHB \[[@REF12], [@REF14]\].

Ischemic and non-ischemic complete heart blocks are dealt as separate entities and we tried to study them head to head. We found no difference in terms of the pre-existing comorbidities including diabetes mellitus, hypothyroidism, hypertension, use of nodal blocking agents or chronic kidney disease. However, the patients with ischemic CHB are younger and frequently have a previous history of coronary artery disease compared to non-ischemic CHB patients. The ejection fraction is also lower in the ischemic CHB group, which is expected because of active myocardial ischemia/infarction. The right ventricular systolic pressure was higher in patients with non-ischemic CHB, which might suggest some relationship with pulmonary hypertension, but this difference was not statistically significant.

In terms of the outcomes, the patients with ischemic CHB are less likely to get a permanent pacemaker, and the difference was statistically significant. This is because most of the CHB after myocardial ischemia resolves spontaneously. The patients with ischemic CHB died more frequently compared to the patients in the non-ischemic group, but this difference was not statistically significant. This suggests that the patients with ischemic CHB do worse than the CHB patients without ischemia.

Conclusions
===========

Patients with ischemic complete heart block are less likely to get a pacemaker. They are younger with a lower ejection fraction at presentation and have a more frequent history of coronary artery disease. We need more studies with a bigger sample size to establish the mortality difference between them.
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